IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Accretion Pharmaceuticals IPO is a Book Building IPO listing on NSE EMERGE exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Jawa Capital Services is the merchant banker of Accretion Pharmaceuticals IPO. It is a SME Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 8th January 2025.
Accretion Pharmaceuticals IPO open date is [●] and close date is [●]. IPO Allotment Date is [●] and Listing date is [●].
IPO
Size:
₹ Cr.
Avg IPO Size (Sector Based)
: ₹
21.21 cr.
Sector: Pharmaceutical
SME
IPO so far:
37
Merchant Banker:
Jawa Capital
SME
IPO by BRLM so far:
4
City:
Ahmedabad
SME
IPO so far:
29
Revenue (annualised):
₹
35.67
cr. 
PE
Ratio:
x
Average Sector PE Ratio: 20.29x
Accretion Pharmaceuticals IPO size is ₹ [●] with IPO price of ₹ [●]. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Jawa Capital Services Private Limited is the book-running lead manager of the Accretion Pharmaceuticals IPO. KFin Technologies Limited is the Registrar for Accretion Pharmaceuticals IPO.
Accretion Pharmaceuticals IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Accretion Pharmaceuticals IPO, based in Ahmedabad, operates in the Pharmaceutical sector with a focus on . The company is launching its SME Upcoming IPO on the NSE EMERGE exchange, using the Book Building Issue method. Accretion Pharmaceuticals IPO size is ₹ [●] with fresh issue size of ₹ [●] and Offer for sale being ₹ Nil
The IPO allotment date for Accretion Pharmaceuticals IPO is expected to be [●], after the finalization of basis of allotment. Investors can check Accretion Pharmaceuticals IPO allotment status on the registrars website, KFin Technologies Limited. Accretion Pharmaceuticals IPO refund dates are [●].
Accretion Pharmaceuticals IPO is expected to be listed on [●].
The upper price band for the Accretion Pharmaceuticals IPO is set at ₹ [●] per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Accretion Pharmaceuticals IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Accretion Pharmaceuticals IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of [●]. After submission, funds are blocked until the basis of allotment of Accretion Pharmaceuticals IPO is finalised.
The merchant banker for Accretion Pharmaceuticals IPO is Jawa Capital Services Private Limited . Jawa Capital Services Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Accretion Pharmaceuticals IPO RHP for further details.
The registrar for Accretion Pharmaceuticals IPO is KFin Technologies Limited. Investors can go to KFin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to Accretion Pharmaceuticals IPO through their official website or helpline.
Accretion Pharmaceuticals IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
[●]
Avg IPO Size (Sector Based)
:
₹ 21.21 Cr.
Sector: Pharmaceutical
SME
IPO so far:
37
Merchant Banker:
Jawa Capital
SME
IPO by BRLM so far:
4
City:
Ahmedabad
SME
IPO so far:
29
Revenue (annualised):
₹ 35.61 cr.
PE
Ratio:
[●]
Average Sector PE Ratio: 20.29x
Accretion Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Accretion Pharmaceuticals Financial Review Page
Merchant Banker(s) of Accretion Pharmaceuticals IPO: Jawa Capital Services Private Limited
Accretion Pharmaceuticals IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Accretion Pharmaceuticals IPO listed at a listing price of against the offer price of .
The current market price of Accretion Pharmaceuticals is .
Why Us?
